Kaye Scholer led the defense before the California Court of Appeal of a joint motion for summary judgment we obtained last year in the Superior Court of California, Alameda County, on behalf of 15 of the leading brand name prescription drug manufacturers and PhRMA, their trade association. Seventeen retail California pharmacies sued under California’s antitrust law claiming that the defendants conspired in violation of the Cartwright Act, California’s antitrust law, to use Canadian drug prices as a floor for setting US prices for prescription drugs, and colluded to prevent re-importation of less expensive drugs from Canada to protect the object of the conspiracy.
The Kaye Scholer team consisted of Saul P. Morgenstern (argued summary judgment in the trial court), Aton Arbisser (argued in the Court of Appeal), Bryant Delgadillo (LA counsel), Karin E. Garvey (NY counsel), Amanda Myers (LA Associate), and Michael Schenk (LA paralegal).
Also of Interest
- NLJ Names Yates a 2016 Litigation Trailblazer December 6, 2016 • Recognitions
- JUVE Handbuch Recommends Frankfurt Office and Lawyers November 14, 2016 • Recognitions
- Kaye Scholer Advises Bregal, Motion Equity in Morrison Utility Services Sale November 7, 2016 • Client Successes
- Kaye Scholer Advises Biohaven on Oversubscribed Private Financing November 4, 2016 • Client Successes
- US News–Best Lawyers Recognizes 32 Kaye Scholer Practices and 41 Lawyers November 1, 2016 • Recognitions
- Compliance Berater Publishes Jungermann Article on Antitrust Follow-On Issues November 1, 2016 • Articles
- Benchmark Litigation Recognizes Kaye Scholer Practices and Partners Nationwide October 24, 2016 • Recognitions
- GIR 100 Names Kaye Scholer a World Leader in Cross-Border Investigations October 10, 2016 • Recognitions
- Antitrust Jurisprudence in the Second Circuit October 1, 2016 • Articles